Improving the Nuclear-Localized Androgen Receptor Splice Variant 7 Test-In Reply

Pascal Bamford¹, Ryan Dittamore¹, Howard I Scher^{2

3}

Affiliations

¹ Epic Sciences, San Diego, California.
² Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
³ Weill Cornell Medical College, New York, New York.

Comment

Pascal Bamford et al. JAMA Oncol. 2019.

. 2019 Mar 1;5(3):434.

doi: 10.1001/jamaoncol.2018.6686.

Pascal Bamford¹, Ryan Dittamore¹, Howard I Scher^{2

3}

¹ Epic Sciences, San Diego, California.
² Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
³ Weill Cornell Medical College, New York, New York.

No abstract available

Comment on

Assessment of the Validity of Nuclear-Localized Androgen Receptor Splice Variant 7 in Circulating Tumor Cells as a Predictive Biomarker for Castration-Resistant Prostate Cancer.
Scher HI, Graf RP, Schreiber NA, Jayaram A, Winquist E, McLaughlin B, Lu D, Fleisher M, Orr S, Lowes L, Anderson A, Wang Y, Dittamore R, Allan AL, Attard G, Heller G. Scher HI, et al. JAMA Oncol. 2018 Sep 1;4(9):1179-1186. doi: 10.1001/jamaoncol.2018.1621. JAMA Oncol. 2018. PMID: 29955787 Free PMC article.
Improving the Nuclear-Localized Androgen Receptor Splice Variant 7 Test.
Nicolazzo C, Gradilone A, Gazzaniga P. Nicolazzo C, et al. JAMA Oncol. 2019 Mar 1;5(3):433-434. doi: 10.1001/jamaoncol.2018.6683. JAMA Oncol. 2019. PMID: 30703189 No abstract available.